Is Meibomian Gland Dysfunction One Disease? Heterogeneity Among Phenotypes
- PMID: 38563551
- PMCID: PMC11442144
- DOI: 10.1097/ICO.0000000000003542
Is Meibomian Gland Dysfunction One Disease? Heterogeneity Among Phenotypes
Abstract
Purpose: The purpose of this study was to examine ocular surface symptoms, tear metrics, and tear cytokines by Meibomian gland dysfunction (MGD) features.
Methods: Symptom questionnaires and an ocular surface evaluation were performed on 40 individuals with varied MGD signs (Meibomian gland [MG] plugging, eyelid vascularity, meibum quality, and MG dropout). Tear proteins were extracted off Schirmer strips and analyzed for 23 human inflammation-related proteins. Statistical analysis was performed to examine associations between dry eye metrics inflammatory proteins and MGD features.
Results: The study involved 40 South Florida veterans with a mean age of 61 ± 13 years; most individuals were male (95%), White (31%), and non-Hispanic (85%). MGD features differentially related to dry eye signs. Eyelid vascularity, meibum quality, and MG dropout, but not MG plugging, correlated with higher corneal staining and lower tear production. MGD features also differentially related to tear cytokines. Eyelid vascularity most closely related to inflammation with significant correlations for interferon-gamma-γ (r = 0.36, P = 0.02), interleukin-4 (IL-4) (r = 0.43, P = 0.006), IL-17A (r = 0.42, P = 0.007), matrix metalloproteinase-2 (r = 0.39, P = 0.01), C-X-C motif chemokine ligand 5 (Regulated upon Activation, Normal T-Cell Expressed and presumably Secreted [RANTES]) (r = 0.32, P = 0.04), and tumor necrosis factor α (r = 0.36, P = 0.02). The other 3 MGD signs were less related to inflammation. Multivariable models revealed IL-4 to be most closely related to eyelid vascularity (standardized β = 0.39, P < 0.0001).
Conclusions: Eyelid vascularity was the MGD sign most closely related to inflammatory cytokines, suggesting that different MGD features may be driven by different pathophysiological mechanisms.
Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
The authors have no funding or conflicts of interest to disclose.
Similar articles
-
Effect of Meibomian Gland Expression on Optical Quality in Patients with Meibomian Gland Dysfunction.Curr Eye Res. 2025 Aug;50(8):785-790. doi: 10.1080/02713683.2025.2497324. Epub 2025 Apr 28. Curr Eye Res. 2025. PMID: 40289677
-
Comparative assessment of structural and tear film alterations in rabbit meibomian gland dysfunction models using chemical and electrocauterization techniques.Sci Rep. 2025 Jul 2;15(1):23494. doi: 10.1038/s41598-025-06923-9. Sci Rep. 2025. PMID: 40603593 Free PMC article.
-
The Yin and Yang of non-immune and immune responses in meibomian gland dysfunction.Ocul Surf. 2024 Apr;32:81-90. doi: 10.1016/j.jtos.2024.01.004. Epub 2024 Jan 14. Ocul Surf. 2024. PMID: 38224775 Free PMC article.
-
Meibomian gland characteristics in children: A narrative review.Ophthalmic Physiol Opt. 2025 Sep;45(6):1244-1260. doi: 10.1111/opo.13552. Epub 2025 Jul 2. Ophthalmic Physiol Opt. 2025. PMID: 40600588 Review.
-
Efficacy of meibomian gland expression combined with Home-Based therapy in the management of dry eye Disease: A systematic review and Meta-Analysis.Cont Lens Anterior Eye. 2024 Apr;47(2):102107. doi: 10.1016/j.clae.2023.102107. Epub 2023 Dec 22. Cont Lens Anterior Eye. 2024. PMID: 38135593
References
-
- Tauber J, Berdy GJ, Wirta DL, et al. NOV03 for Dry Eye Disease Associated with Meibomian Gland Dysfunction: Results of the Randomized Phase 3 GOBI Study. Ophthalmology 2022. - PubMed
-
- Mudgil P Antimicrobial role of human meibomian lipids at the ocular surface. Invest Ophthalmol Vis Sci 2014;55(11):7272–7. - PubMed
-
- Gurnani B, Kaur K. Meibomian Gland Disease. StatPearls. Treasure Island (FL)2023.
MeSH terms
Substances
Grants and funding
- U01 EY034686/EY/NEI NIH HHS/United States
- R61EY032468/EY/NEI NIH HHS/United States
- I01 BX004893/BX/BLRD VA/United States
- W81XWH-20-1-0820/Vision Research Program (VRP)
- P30EY014801/NIH Center Core Grant
- BX004893/Veterans Association Clinical Sciences Biomedical Laboratory R&D
- I21 RX003883/RX/RRD VA/United States
- I01 CX002015/CX/CSRD VA/United States
- U24 EY035102/EY/NEI NIH HHS/United States
- W81XWH-20-1-0579/Department of Defense Gulf War Illness Research Program (GWIRP)
- R33 EY032468/EY/NEI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical